MASSACHUSETTS
-
Continuous Glucose Monitors Drives Growth of the Diabetes Technology Market, Finds IDTechEx
BOSTON, April 11, 2022 /PRNewswire/ -- IDTechEx has recently released "Diabetes Management Technologies 2022-2032: Markets, Players, and Forecasts", a market research report exploring the technical, r…
-
Ardelyx and Kyowa Kirin Amend License Agreement for Tenapanor
WALTHAM, Mass., April 11, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicin…
-
Flagship Pioneering Bolsters Executive Team with Appointment of Michelle C. Werner as CEO-Partner and CEO of Alltrna
Werner Brings More Than Two Decades of Pharmaceutical Leadership to the Role CAMBRIDGE, Mass., April 11, 2022 /PRNewswire/ -- Flagship Pioneering, the bioplatform innovation company, today announced i…
-
Myeloid Therapeutics Presents Late-Breaking Data at AACR 2022 Demonstrating the Ability of its ATAK™ Receptors and in vivo Delivery of mRNA to Attack Cancer by Immune Reprogramming
CAMBRIDGE, Mass., April 10, 2022 /PRNewswire/ -- Myeloid Therapeutics, Inc. ("Myeloid"), a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases, toda…
-
HotSpot Therapeutics Presents Pre-Clinical Data on CBL-B Program at American Association for Cancer Research Annual Meeting 2022
In Vitro and In Vivo Data for CBL-B Inhibitor Demonstrated Differentiated Immune Enhancing Activity BOSTON, April 8, 2022 /PRNewswire/ -- HotSpot Therapeutics, Inc., a biotechnology company pioneering…
-
Nuvalent Presents New Data Demonstrating Expanded Preclinical Activity with ROS1-Selective Inhibitor NVL-520 and ALK-Selective Inhibitor NVL-655 at AACR Annual Meeting 2022
NVL-520 showed strong preclinical activity against diverse ROS1 fusion partners and kinase-domain resistance mutations, as well as in a ROS1-driven model of glioblastoma NVL-655 demonstrated different…
-
Omega Therapeutics Presents Preclinical Data on OTX-2002, First-in-Class Epigenomic Controller, as Potential Treatment for Hepatocellular Carcinoma at the AACR Annual Meeting 2022
OTX-2002 suppresses c-Myc gene expression resulting in a loss of cancer cell viability in vitro and reduces tumor growth in in vivo xenograft modelsData support the potential of the OMEGA Epigenomic P…
-
Corbus Presents First Preclinical Data for CRB-601 at the American Association for Cancer Research (AACR) Annual Meeting
NORWOOD, Mass., April 8, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), an immunology company, announced today the first preclinical data for CR…
-
Blueprint Medicines Announces BLU-945 Proof-of-Concept Data Supporting Initiation of Comprehensive Combination Development Strategy in EGFR-mutant Non-Small Cell Lung Cancer
-- Early dose escalation data show dose-dependent reductions in ctDNA and tumor burden -- -- Generally well-tolerated with most AEs Grade 1 or 2, supporting continued dose escalation -- -- Initiating…
-
BrickBio Debuts Powerful Advantage of Novel ADCs, Protein Origami, and Synthetic Virology at 2022 AACR
BOSTON, April 8, 2022 /PRNewswire/ -- BrickBio, the leader in RNA facilitated site-specific conjugation for novel protein therapeutics, will be presenting an invited poster at the annual meeting of th…
-
Lyra Therapeutics Announces $100.5 Million Private Placement
WATERTOWN, Mass., April 8, 2022 /PRNewswire/ -- Lyra Therapeutics, Inc. (Nasdaq: LYRA) today announced that it has entered into a securities purchase agreement to sell securities in a private placemen…
-
BankProv Partners with Synctera to Create Card Program in Support of Banking-as-a-Service Model
The partnership will help expand BankProv's BaaS offerings to clients nationwide through Synctera's innovative FinTech integrations AMESBURY, Mass., April 8, 2022 /PRNewswire/ -- BankProv, subsidiary…
-
Harvard Business School Announces New Robert K. Kraft Family Fellowship Fund
Fund to Enable HBS to Attract Students with Highest Potential for Leadership BOSTON, April 7, 2022 /PRNewswire/ -- Harvard Business School (HBS) has announced the establishment of the Robert K. Kraft…
-
Keurig Dr Pepper Announces Pricing of $3.0 billion of Senior Notes
BURLINGTON, Mass. and FRISCO, Texas, April 7, 2022 /PRNewswire/ -- Keurig Dr Pepper Inc. (NASDAQ: KDP) announced today the pricing of its previously announced public offering of senior notes (collecti…
-
Constant Contact Closes Acquisition of Vision6
Acquisition will expand Constant Contact's international footprint WALTHAM, Mass. and BRISBANE, Australia, April 7, 2022 /PRNewswire/ -- Constant Contact, a digital marketing platform used by millions…
-
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
LEXINGTON, Mass., April 7, 2022 /PRNewswire/ -- Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of innovative therapeutics for the treatment of cancer, today announced t…
-
Aclarity Receives Investment to Deploy Their PFAS Destruction Technology to Eliminate Cancerous Chemicals from Water
The company's Seed funding round was led by Burnt Island Ventures with participation from DCVC, MassVentures, and the UMass Maroon Fund. WORCESTER, Mass., April 7, 2022 /PRNewswire/ -- Aclarity, a wat…
-
The Hanover Insurance Group, Inc. to Hold Virtual Annual Meeting of Shareholders on May 10
WORCESTER, Mass., April 7, 2022 /PRNewswire/ -- The Hanover Insurance Group, Inc. (NYSE: THG) will hold its annual meeting of shareholders on Tuesday, May 10, 2022, at 9:00 a.m. ET. The meeting will b…
-
PROOF DIAGNOSTICS SUBMITS REQUEST FOR EMERGENCY USE AUTHORIZATION SEEKING FIRST APPROVAL OF CRISPR-BASED MOLECULAR POINT-OF-CARE COVID-19 TEST
If authorized by the FDA, the Proof Lab Test System may be used to deliver accurate, actionable, lab-quality results for COVID-19 (SARS-CoV-2) in as little as 18 minutes CAMBRIDGE, Mass., April 7, 202…
-
Nationwide Earns Honors for Industry-Leading Customer Experience Across Multiple Touchpoints
DALBAR presents Customer Experience Excellence Award to Nationwide for 3rd Consecutive Year MARLBOROUGH, Mass., April 7, 2022 /PRNewswire/ -- DALBAR announced that Nationwide has earned DALBAR's